Back |
home / stock / allk / allk message board
Subject | By | Source | When |
---|---|---|---|
Maybe they'll buy their own stock. LOL. | sirglenn | investorshub | 12/23/2021 2:29:22 PM |
And GOLDMAN lowered the price target to $60.00...(6X) | Justfactsmam | investorshub | 12/23/2021 1:41:41 PM |
9.91 > Morgan Stanley Maintains Equal-Weight on Allakos, | crudeoil24 | investorshub | 12/23/2021 12:25:55 PM |
Expecting $15-$20 next week . | FROZENFLAME | investorshub | 12/23/2021 12:01:40 PM |
Over $10 premarket . | FROZENFLAME | investorshub | 12/23/2021 11:52:46 AM |
Its never too late :) | maximumgriff | investorshub | 12/23/2021 9:10:58 AM |
Wish I was short here....holy smokes | Tom turtles | investorshub | 12/23/2021 9:08:55 AM |
500 mill cash on hand? | alchemytrader | investorshub | 12/23/2021 4:37:09 AM |
we will...but if it doesnt happen tomorrow then | alchemytrader | investorshub | 12/23/2021 4:35:43 AM |
last | TheFinalCD | investorshub | 12/23/2021 2:11:30 AM |
#$ALLK ?? Stock down 90% & Analyst price | da_stock_analyst | investorshub | 12/23/2021 1:48:57 AM |
AH pps of $9.55 a $1 rebound from | Wind_Storm | investorshub | 12/23/2021 1:26:17 AM |
Don't know about $30-$35 without positive news...but | Justfactsmam | investorshub | 12/22/2021 11:53:09 PM |
What happened here? | MD3 | investorshub | 12/22/2021 11:30:21 PM |
I wonder if this will rebound tomorrow? $30-$35? | tiger_trader | investorshub | 12/22/2021 11:19:59 PM |
News, Short Squeeze, Breakout and More Instantly...
Allakos Inc. Company Name:
ALLK Stock Symbol:
NASDAQ Market:
SAN CARLOS, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- Allakos Inc. (the “Company”) (Nasdaq: ALLK), a biotechnology company developing antibodies for the treatment of allergic, inflammatory and proliferative diseases, today provided a business update and reported financial results for...
SAN CARLOS, Calif., March 14, 2024 (GLOBE NEWSWIRE) -- Allakos Inc. (the “Company”) (Nasdaq: ALLK), a biotechnology company developing antibodies for the treatment of allergic, inflammatory and proliferative diseases, today provided a business update and reported financial results f...